Guidelines for Authors

The Monaldi Archives for Chest Disease publishes the following article types:

  • Articles
  • Reviews
  • Case Reports
  • Perspectives/Letters to the Editor

Overview

Manuscript will be carefully scrutinized for evidence of plagiarism, duplication and data manipulation; in particular, images will be carefully examined for any indication of intentional improper modification.

Any suspected misconduct ends up with a quick rejection and is then reported to the US Office of Research Integrity.

Ensure that your work is written in correct English before submission.
Professional copyediting can help authors improve the presentation of their work and increase its chances of being taken on by a publisher. In case you feel that your manuscript would benefit from a professional a professional English language copyediting checking language grammar and style, you can find a reliable revision service at:

The Corresponding Author (multiple corresponding authors are not allowed) must submit the manuscript online-only through our Manuscript Submission System.

Authors are kindly invited to suggest potential reviewers (names, affilitations and email addresses) for their manuscript, if they wish.

 

Declarations

All manuscripts must contain the following sections:

  • Ethics approval and consent to participate
  • Consent for publication
  • Availability of data and material
  • Competing interests
  • Funding
  • Authors' contributions
  • Acknowledgements

Preparing your manuscript

Original Articles (3500 words max, abstract 350 words max, 50 references max, 3/5 tables and/or figures): Reports of basic and applied research in the field of cardiopulmonary medicine and rehabilitation. Original Articles should be divided into an Abstract, Introduction, Materials and Methods, Results, Discussion, Conclusions and References. A maximum of 10 authors is permitted and additional authors should be listed in an ad hoc Appendix.

Reviews (5000 words max, abstract 250 words max, 40 to 100 references, 3/5 tables and/or figures): They should be introduced by a general summary of content in the form of an Abstract. Following a short Introduction, putting the study into context and defining the aim, reviews will concentrate on the most recent clinical updates in the field and summarize the state-of-the-art literature. A review should clearly describe the search strategy followed (key words, inclusion, exclusion criteria, search engines, ...). No particular format is required; headings should be used to designate the major divisions of the paper.

Case Reports (about 2000 words, abstract 150 words max, 20 references max, 3 tables and/or figures): Reports describing observations on clinical cases that can be educational, including adverse effects of drugs or outcomes of a specific treatment. They should be divided into: Abstract, Introduction (optional), Case report(s), Discussion, Conclusions and References.

Perspectives / Letters to the Editor (1000 words max,  abstract optional, 3 references): Letters should address specific scientific issues raised by papers published by Monaldi Archives for Chest Disease or deliver information/news regarding an issue related to the Journal scope. Authors of papers cited in the Letters will be given the opportunity to respond. Letters that are highly polemic will not be published. Letters are not peer reviewed and are published at the discretion of the Monaldi Archives for Chest Disease editors. Conclusions and opinions expressed by the authors do not necessarily reflect the policies of Monaldi Archives for Chest Disease.

Each manuscript should be typewritten, double-spaced throughout; pages should be in A4 format (2.5 cm margin left & right) and numbered, lines should be left numbered in continuum (10-digit numeric system). Headings must be used to designate the major divisions of the paper.

The first page must contain:
i) title (lowercase), without acronyms; 
ii) first name and family name of each author, separated by commas;
iii) affiliation(s) of each author (in English);
iv) acknowledgments
v) full name and full postal address of the corresponding author (please note that multiple corresponding authors are not allowed). Phone, fax number and e-mail address for the correspondence should also be included; 
vi) three to five key words.

The second page should contain:

  1. authors’ contributions, e.g., information about the contributions of each person named as having participated in the study;
  2. disclosures about potential conflict of interests;
  3. further information (e.g., funding, conference presentation ...);
  4. Declarations about ethics approval, informed consent, etc.

The Abstract must be analytically informative and not subdivided in headings. The Text should normally be subdivided into Introduction, Materials and Methods, Results, Discussion.

If tables are used, they should be double-spaced on separate pages, not embedded throughout the text. They should be numbered and cited in the text. If figures are used, they should be numbered and cited in the text  and inserted at the end of the manuscript for the peer-review process; in case of acceptance, authors are required to provide the figures as .tiff or .jpg files, with the following digital resolution:

  1. color (saved as CMYK): minimum 300 dpi;
  2. black and white/grays: minimum 600 dpi;
  3. one column width (8.5 cm) or 2 column widths (17.5 cm).

A different caption for each figure must be provided at the end of the manuscript. Figures with different panels have to be grouped into a plate, and panels marked with letters.

If abbreviations are used in the text, authors are required to write full name+abbreviation in brackets [e.g. Multiple Myeloma (MM)] the first time they are used in the Abstract and in the first manuscript section, then only abbreviations can be written (apart from titles; in this case authors have to write always the full name). If names of equipment or substances are mentioned in the text, brand, company names and locations (city and state) for equipment and substances should be included in parentheses within the text.

Numbers
For numbers less than one use zero to the left of the decimal, e.g. 0.23. Do not use commas for four digit numbers, e.g. 9000, and use commas for numbers with more than four digits, e.g. 90,000.

References
References should be prepared strictly according to the Vancouver style and must be numbered consecutively in the order in which they are first cited in the text (not alphabetical order); they must be identified in the text as number in square brackets. References to personal communications and unpublished data should be incorporated in the text and not placed under the numbered references [Example: (Wright 2011, unpublished data) or (Wright 2011, personal communication)]. Where available, URLs for the references should be provided directly within the MS-Word document. Authors are responsible for the accuracy of their references. References in the References section must be prepared as follows:

  1. More than three authors, cite 3 authors, et al. If the paper has only 4 authors, cite all authors;
  2. title style: sentence case; please use a capital letter only for the first word of the title;
  3. journal titles mentioned in the References list should be abbreviated according to the following websites:
    1. ISI Journal Abbreviations Index (http://library.caltech.edu/reference/abbreviations/);
    2. Biological Journals and Abbreviations (http://home.ncifcrf.gov/research/bja/);
    3. Medline List of Journal Titles (ftp://ftp.ncbi.nih.gov/pubmed/J_Medline.txt).
  4. put year after the journal name;
  5. never put month and day in the last part of the references;
  6. cite only the volume (not the issue in brackets);
  7. pages have to be abbreviated, e.g., 351-8.

To ensure the correct citation format, please check your references in the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed).

Examples:

Standard journal article
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002;347:284-7.

Proceedings
Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, eds. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming, 2002 Apr 3-5, Kinsdale, Ireland. Berlin: Springer; 2002. pp 182-91.

Article with organization as author
Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension 2002;40:679-86.

Books
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis, MO: Mosby; 2002.
Bjørn Lomborg, ed. RethinkHIV - Smarter ways to invest in ending HIV in Sub-Saharan Africa. Cambridge: Cambridge University Press; 2012.
Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, eds. The genetic basis of human cancer. New York, NY: McGraw-Hill; 2002. pp 93-113.

Permissions

In case extracts (text/figures/tables) from other copyrighted works are included, the author(s) must obtain written permission from the copyright holder(s) and credit the source(s) in the article, for example: 'Adapted from Kovačević et al., Monaldi Arch Chest Dis 2013;79:61-66; with permission.' The editorial office of Monaldi Archives for Chest Disease needs to receive a copy of the written permission before proceeding with publication.

Peer-review policy

All manuscripts submitted to our journal are critically assessed by external and/or in-house experts in accordance with the principles of peer review, which is fundamental to the scientific publication process and the dissemination of sound science. Each paper is first assigned by the Editors to an appropriate Associate Editor who has knowledge of the field discussed in the manuscript. The first step of manuscript selection takes place entirely in-house and has two major objectives: i) to establish the article appropriateness for our journals readership; ii) to define the manuscript priority ranking relative to other manuscripts under consideration, since the number of papers that the journal receives is much greater than it can publish. If a manuscript does not receive a sufficiently high priority score to warrant publication, the editors will proceed to a quick rejection. The remaining articles are reviewed by at least two different external referees (second step or classical peer review). Manuscripts should be prepared according to the Uniform Requirements established by the International Committee of Medical Journal Editors (ICMJE).

Authorship and Contributorship
All persons designated as authors should qualify for authorship according to the ICMJE criteria. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should only be based on substantial contributions to: i) conception and design, or analysis and interpretation of data, and to ii) drafting the article or revising it critically for important intellectual content; and on iii) final approval of the version to be published; and iv) agreement to be accountable for all aspects of the work. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Authors should provide a brief description of their individual contributions.
Those who do not meet all four criteria should not be listed as authors, but they should be acknowledged. Those whose contributions do not justify authorship may be acknowledged individually or together as a group under a single heading. Authors can find detailed information on the Publisher's web site.

Changes in Authorship
If authors request removal or addition of an author after manuscript submission or during the peer-review process, the journal editors should receive a letter clearly explaining the reason for the change. Authors are also requested to sign and send to the Editors a statement of agreement for the requested change from all listed authors and from the author to be removed or added.
Please note that if your manuscript is accepted you will not be able to make any changes to the authors, or order of authors, of your manuscript once the editor has accepted your manuscript for publication.

No changes to the Authors or Corresponding Author can be made after publication of the article, either as an “Advance Online Article” or in the regular issue. Instead, a corrigendum may be considered by the journal editor.

Obligation to Register Clinical Trials 
The ICMJE believes that it is important to foster a comprehensive, publicly available database of clinical trials. The ICMJE defines a clinical trial as any research project that prospectively assigns human subjects to intervention or concurrent comparison or control groups to study the cause-and-effect relationship between a medical intervention and a health outcome. Medical interventions include drugs, surgical procedures, devices, behavioral treatments, process-of-care changes, etc. Our journals require, as a condition of consideration for publication, registration in a public trials registry. The journal considers a trial for publication only if it has been registered before the enrollment of the first patient. The journal does not advocate one particular registry, but requires authors to register their trial in a registry that meets several criteria. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a non-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include a minimum of data elements (http://www.icmje.org/about-icmje/faqs/clinical-trials-registration/). For example, ClinicalTrials.gov (http://www.clinicaltrials.gov), sponsored by the United States National Library of Medicine, meets these requirements.

Protection of Human Subjects and Animals in Research
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. An Informed Consent statement is always required from patients involved in any experiments. When reporting experiments on animals, authors should indicate whether the institutional and national guide for the care and use of laboratory animals was followed.  Further guidance on animal research ethics is available from the World Medical Association (2016 revision). When reporting experiments on ecosystems involving non-native species, Authors are bound to ensure compliance with the institutional and national guide for the preservation of native biodiversity.